Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.82
Delayed Data
As of Aug 28
 +0.02 / +1.11%
Today’s Change
0.97
Today|||52-Week Range
2.02
-3.70%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.80
Today’s open1.80
Day’s range1.79 - 1.85
Volume459,345
Average volume (3 months)539,389
Market cap$274.3M
Dividend yield--
Data as of 4:04pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+20.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...+0.79+4.97%
SNTASynta Pharmaceutical...+0.08+4.04%
EGLTEgalet Corp+0.26+2.50%
--China Health Group I...0.000.00%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

Partner Offers